British drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs compared with a year earlier. Following the update, the group's share price edged up 0.1 percent in early trading on London's top-tier FTSE 100 index, as the group also upgraded its full-year outlook for sales.